Full Papers
doi.org/10.1002/cplu.202000779
ChemPlusChem
3-chloroperoxybenzoic acid (mcpba) were purchased from Bide
Pharmatech Ltd., of China. All other organic solvents, including
ethanol, methanol (MeOH), acetone, chloroform, dichloromethane
(DCM), and ethyl acetate (EA), and Na2CO3 were of analytical grade
and obtained commercially from the Beijing Company of China
National Medicals.
Ternary Pyr/Per@DITFB·BPNO cocrystals: DITFB, BPNO and Pyr or
Per in a 2:2:1 molar ratio were dissolved in the chloroform in a
glass vial, which was sealed using Parafilm with pinholes and kept
in the dark at room temperature to slowly evaporate the solvent.
Well-formed crystals suitable for XRD measurement appeared
within approximately one to two weeks.
1
2
3
4
5
6
7
8
9
Synthesis of BPNO
Single crystal X-ray diffraction analysis
4-([1,1’-Biphenyl]-4-yl)pyridine-N-oxide (4-biphenylpyridine N-oxide,
BPNO) was synthesized according to the pathway shown in
Scheme 1 and the detail procedure is subsequently described.
All the single-crystal XRD data of the cocrystals were collected
using a SuperNova Rigaku Oxford Diffraction diffractometer with
dual X-ray sources (Cu and Mo, CuÀ Kα radiation, λ=1.5418 Å, were
selected for the experiments). Using Olex2,[56] the structure was
solved with the ShelXT[57] structure solution program using direct
methods and refined with the olex2.refine[58] refinement package
using Gauss-Newton minimization. Hydrogen atoms were added
according to the theoretical analysis.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
4-([1,1’-Biphenyl]-4-yl)pyridine: A mixture of 4-bromopyridine (3 g,
18.9 mmol), [1,1’-biphenyl]-4-ylboronic acid (4.5 g, 22.7 mmol), Pd-
(PPh3)4 (1.09 g, 0.945 mmol), and Na2CO3 (4 g, 37.8 mmol) in 1,4-
°
dioxane (40 mL) and H2O (5 mL) was heated at 90 C for 18 h under
a N2 atmosphere. The reaction mixture was cooled to room
temperature and filtered through a celite pad. The resulting filtrate
was concentrated under reduced pressure to give the crude
mixture, which was diluted with EA (50 mL), washed with water and
brine, dried over Na2SO4, and filtered. The filtrate was concentrated
under vacuum to give a crude product, which was purified by flash
column chromatography (silica gel, eluting with 5% to 8% MeOH/
DCM) to afford 4-([1,1’-biphenyl]-4-yl)pyridine (3.2 g, 73%) as a
DITFB·BPNO) contain(s) the supplementary crystallographic data
for this paper. These data are provided free of charge by the joint
Cambridge Crystallographic Data Centre and Fachinformationszen-
white solid. HPLC/UV purity: 100%; LC-MS (ESI): 232.2 (M+1)+. H
NMR (DMSO-d6): (ppm) 8.65–8.66 (dd, J=6 Hz, 1.6 Hz, 2H), 7.91–
7.93 (d, J=8.4 Hz, 2H), 7.82–7.84 (d, J=8.4 Hz, 2H), 7.74–7.78 (m,
4H), 7.48–7.52 (m, 2H), 7.39–7.42 (m, 1H).
1
Luminescence measurements
Steady fluorescence spectra of the samples and decay profiles of
their luminescence were measured using an FLS980 Spectrometer
(Edinburgh Instruments Ltd.). The fluorescence lifetimes (τ) were
obtained by fitting the decay curves. The τ of the samples were
obtained by deconvolution fitting (fluorescence) or tail fitting
(phosphorescence) of the decay curve with a multi-exponential
decay function of I(t)=A1exp(À t/τ1)+A2exp(À t/τ2)+···+Aiexp(À t/
τi), where Ai and τi represent the amplitudes and lifetimes of the
individual components of the multi-exponential decay profiles. The
mean lifetime was estimated as <τ> =A1τ1 +A2τ2 +···+Aiτi (where
Ai represents the normalized coefficient defined as Ai =Ai/�Ai (i=
1~n)).
4-([1,1’-Biphenyl]-4-yl)pyridine-N-oxide (BPNO): To a solution of 4-
([1,1’-biphenyl]-4-yl)pyridine (3.2 g, 13.8 mmol) in DCM (30 mL) was
added 3-chloroperoxybenzoic acid (mcpba, 3.35 g, 16.5 mmol, 85%
°
) dropwise at 0 C (icy water) under N2. Then, the mixture was
stirred at room temperature for 18 h. The reaction mixture was
quenched with ice water (100 mL), and then extracted with DCM
(60 mL×3). The organic layer was washed with aqueous NaHCO3
(50 mL×3), water (50 mL), and brine (50 mL), dried over Na2SO4,
concentrated, and purified by flash column chromatography (silica
gel, eluting with 8% to 10% MeOH/DCM) to afford 4-([1,1’-
biphenyl]-4-yl)pyridine-1-oxide (2.5 g, 74%) as a white solid. HPLC/
UV purity: 100%; LC-MS (ESI): 248.3(M+1)+. 1H NMR (DMSO-d6):
(ppm) 8.29–8.30 (dd, J=8 Hz, 2.8 Hz, 2H), 7.79–7.90 (m, 6H), 7.42
(dd, J=8.0 Hz, 2.8 Hz, 2H), 7.48–7.51 (m, 2H), 7.38–7.42 (m, 1H).
The absolute quantum yields of the three oligomers at room
temperature were estimated by using an integrating sphere (F-
M101, Edinburgh) accessory in an FLS980 fluorescence spectrom-
eter (Edinburgh Instruments Ltd.).
Growth of Cocrystals
Computational methods
BPNO Crystal: 0.1 mmol BPNO was dissolved in 5 mL of chloroform
in a glass vial, which was sealed using Parafilm with pinholes and
kept in the dark at room temperature to slowly evaporate the
solvent. Well-formed crystals suitable for X-ray diffraction (XRD)
measurements appeared within approximately one to two weeks.
All calculations were carried out with the GAUSSIAN 09 quantum
chemistry package[59] in the electronic ground state using density
functional theory (DFT). The structures of all the monomers and
binary and ternary cocrystals were determined from the XRD data
and calculated by the M06-2X method.[60] The Lanl2dz ECP basis set
was used to describe the I atoms, while aug-cc-pVDZ was applied
for all the other atoms. The interaction energies were obtained by a
single point energy prediction based on the structures of single
Binary DITFB·BPNO cocrystal: DITFB and BPNO in a 1:1 molar ratio
were dissolved in 10 mL of acetone or 1:1 ethanol-acetone in a
glass vial, which were sealed using Parafilm with pinholes and kept
in the dark at room temperature to slowly evaporate the solvent.
Well-formed crystals suitable for XRD measurement appeared
within approximately one to two weeks.
~
crystals, and the interaction energy ( E) of each complex was
defined as the difference between the total energy of the complex
and the sum of the total energies of the monomers.
Acknowledgements
The authors thank the Science and Technology Innovation Project
of Shanxi Colleges and Universities (No. 2020L0476), Applied Basic
Scheme 1. Synthesis pathway of BPNO.
ChemPlusChem 2021, 86, 252–258
257
© 2021 Wiley-VCH GmbH